B
Elevance Health, Inc. ELV
$528.99 $2.030.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
B
Buy 2/8/2024Upgraded
Elevance Health, Inc. (ELV) was upgraded to B from B- on 2/8/2024 due to a noticeable increase in the volatility index.
B
Buy 12/21/2023Upgraded
Elevance Health, Inc. (ELV) was upgraded to B- from C+ on 12/21/2023 due to an increase in the volatility index.
C
Hold 10/31/2023Downgrade
Elevance Health, Inc. (ELV) was downgraded to C+ from B- on 10/31/2023 due to a major decline in the growth index, volatility index and efficiency index. Net income declined 30.44% from $1.85B to $1.29B, earnings per share declined from $7.79 to $5.45, and EBIT declined 2.18% from $2.7B to $2.64B.
B
Buy 6/27/2023Downgrade
Elevance Health, Inc. (ELV) was downgraded to B- from B on 6/27/2023 due to a decline in the volatility index and total return index.
B
Buy 6/12/2023Upgraded
Elevance Health, Inc. (ELV) was upgraded to B from B- on 6/12/2023 due to an increase in the total return index.
B
Buy 5/22/2023Downgrade
Elevance Health, Inc. (ELV) was downgraded to B- from B on 5/22/2023 due to a substantial decline in the total return index, growth index and volatility index.
B
Buy 1/12/2023Downgrade
Elevance Health Inc. (ELV) was downgraded to B from B+ on 1/12/2023 due to a noticeable decline in the total return index.
B
Buy 12/23/2022Downgrade
Elevance Health Inc. (ELV) was downgraded to B+ from A- on 12/23/2022 due to a noticeable decline in the total return index.
A
Buy 12/8/2022Upgraded
Elevance Health Inc. (ELV) was upgraded to A- from B+ on 12/8/2022 due to a large increase in the total return index and valuation index.
B
Buy 11/2/2022Upgraded
Elevance Health Inc. (ELV) was upgraded to B+ from B on 11/2/2022 due to an increase in the total return index, growth index and solvency index. Operating cash flow increased 100.82% from $2.45B to $4.92B, total revenue increased 3.38% from $38.63B to $39.94B, and debt to equity declined from 0.66 to 0.65.
B
Buy 7/21/2022Downgrade
Elevance Health Inc. (ELV) was downgraded to B from B+ on 7/21/2022 due to a decline in the growth index, solvency index and valuation index. Earnings per share declined from $7.39 to $6.79, EBIT declined 6.96% from $2.53B to $2.35B, and operating cash flow declined 3.5% from $2.54B to $2.45B.
B
Buy 6/23/2022Downgrade
Anthem, Inc. (ANTM) was downgraded to B+ from A- on 6/23/2022 due to a large decline in the total return index and volatility index.
A
Buy 6/8/2022Upgraded
Anthem, Inc. (ANTM) was upgraded to A- from B+ on 6/8/2022 due to an increase in the volatility index.
B
Buy 5/23/2022Downgrade
Anthem, Inc. (ANTM) was downgraded to B+ from A- on 5/23/2022 due to a decline in the total return index and volatility index.
A
Buy 4/25/2022Upgraded
Anthem, Inc. (ANTM) was upgraded to A- from B+ on 4/25/2022 due to a large increase in the growth index, total return index and valuation index. Earnings per share increased from $4.6314 to $7.39, operating cash flow increased 51.97% from $1.67B to $2.54B, and EBIT increased 38.16% from $1.83B to $2.53B.
B
Buy 4/18/2022Upgraded
Anthem, Inc. (ANTM) was upgraded to B+ from B on 4/18/2022 due to a large increase in the total return index, volatility index and efficiency index. Total capital increased 1.03% from $59.54B to $60.16B.
B
Buy 11/3/2021Upgraded
Anthem, Inc. (ANTM) was upgraded to B from B- on 11/3/2021 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 48.78% from $1.68B to $2.5B, and total revenue increased 5.82% from $33.85B to $35.82B.
B
Buy 10/14/2021Downgrade
Anthem, Inc. (ANTM) was downgraded to B- from B on 10/14/2021 due to a decline in the total return index and volatility index.
B
Buy 9/29/2021Upgraded
Anthem, Inc. (ANTM) was upgraded to B from B- on 9/29/2021 due to an increase in the total return index.
B
Buy 8/17/2021Downgrade
Anthem, Inc. (ANTM) was downgraded to B- from B on 8/17/2021 due to a large decline in the growth index, valuation index and efficiency index. Operating cash flow declined 32.81% from $2.51B to $1.68B.
B
Buy 3/11/2021Upgraded
Anthem, Inc. (ANTM) was upgraded to B from B- on 3/11/2021 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 431.57% from -$1.15B to $3.81B, earnings per share increased from $0.87 to $2.1943, and total revenue increased 2.14% from $31.16B to $31.83B.
B
Buy 10/30/2020Downgrade
Anthem, Inc. (ANTM) was downgraded to B- from B on 10/30/2020 due to a large decline in the growth index, valuation index and solvency index. Operating cash flow declined 120.87% from $5.51B to -$1.15B, earnings per share declined from $8.91 to $0.87, and EBIT declined 45.78% from $3.35B to $1.82B.
B
Buy 10/8/2020Upgraded
Anthem, Inc. (ANTM) was upgraded to B from B- on 10/8/2020 due to a noticeable increase in the growth index, total return index and solvency index. Operating cash flow increased 119.09% from $2.52B to $5.51B, earnings per share increased from $5.94 to $8.91, and EBIT increased 46.8% from $2.28B to $3.35B.
B
Buy 3/23/2020Downgrade
Anthem, Inc. (ANTM) was downgraded to B- from B on 3/23/2020 due to a decline in the growth index, volatility index and total return index. EBIT declined 22.94% from $1.67B to $1.29B, earnings per share declined from $4.55 to $3.6202, and operating cash flow declined 20.4% from $1.67B to $1.33B.
B
Buy 12/26/2019Upgraded
Anthem, Inc. (ANTM) was upgraded to B from B- on 12/26/2019 due to an increase in the volatility index.
B
Buy 10/29/2019Downgrade
Anthem, Inc. (ANTM) was downgraded to B- from B on 10/29/2019 due to a substantial decline in the total return index, volatility index and valuation index.
B
Buy 2/5/2019Downgrade
Anthem, Inc. (ANTM) was downgraded to B from B+ on 2/5/2019 due to a decline in the valuation index, dividend index and volatility index.
B
Buy 12/31/2018Upgraded
Anthem, Inc. (ANTM) was upgraded to B+ from B on 12/31/2018 due to a noticeable increase in the volatility index, valuation index and efficiency index. Total capital increased 1.27% from $48.63B to $49.25B.
B
Buy 2/23/2018Downgrade
Anthem, Inc. (ANTM) was downgraded to B from B+ on 2/23/2018 due to a significant decline in the growth index, volatility index and dividend index. Operating cash flow declined 154.11% from $2.4B to -$1.3B, and EBIT declined 55.41% from $1.27B to $566M.
B
Buy 12/20/2017Upgraded
Anthem, Inc. (ANTM) was upgraded to B+ from B on 12/20/2017 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 511.73% from $393.1M to $2.4B, and total revenue increased 0.02% from $22.42B to $22.43B.
B
Buy 10/11/2017Upgraded
Anthem, Inc. (ANTM) was upgraded to B from B- on 10/11/2017 due to a noticeable increase in the total return index and volatility index.
B
Buy 9/26/2017Downgrade
Anthem, Inc. (ANTM) was downgraded to B- from B on 9/26/2017 due to a major decline in the growth index, total return index and volatility index. Operating cash flow declined 85.38% from $2.69B to $393.1M, EBIT declined 20.11% from $1.75B to $1.4B, and earnings per share declined from $3.73 to $3.16.
B
Buy 4/28/2017Upgraded
Anthem, Inc. (ANTM) was upgraded to B from B- on 4/28/2017 due to a significant increase in the growth index, total return index and valuation index. Operating cash flow increased 878.59% from $274.7M to $2.69B, earnings per share increased from $1.371 to $3.73, and EBIT increased 115.39% from $812.2M to $1.75B.
B
Buy 12/7/2016Upgraded
Anthem, Inc. (ANTM) was upgraded to B- from C+ on 12/7/2016 due to an increase in the volatility index, total return index and solvency index. Debt to equity declined from 0.7 to 0.69.
C
Hold 11/1/2016Downgrade
Anthem, Inc. (ANTM) was downgraded to C+ from B- on 11/1/2016 due to a decline in the volatility index.
B
Buy 10/4/2016Upgraded
Anthem, Inc. (ANTM) was upgraded to B- from C+ on 10/4/2016 due to a noticeable increase in the solvency index, valuation index and dividend index.
C
Hold 7/29/2016Downgrade
Anthem, Inc. (ANTM) was downgraded to C+ from B- on 7/29/2016 due to a substantial decline in the growth index, volatility index and valuation index. Operating cash flow declined 49.24% from $1.3B to $662M.
B
Buy 3/18/2016Downgrade
Anthem, Inc. (ANTM) was downgraded to B- from B on 3/18/2016 due to a large decline in the volatility index, total return index and valuation index.
B
Buy 3/7/2016Downgrade
Anthem, Inc. (ANTM) was downgraded to B from B+ on 3/7/2016 due to a decline in the total return index, valuation index and dividend index.
B
Buy 2/19/2016Upgraded
Anthem, Inc. (ANTM) was upgraded to B+ from B on 2/19/2016 due to a large increase in the growth index, volatility index and dividend index. Operating cash flow increased 176.38% from $343.4M to $949.1M, and total revenue increased 1.44% from $19.9B to $20.19B.
B
Buy 2/8/2016Downgrade
Anthem, Inc. (ANTM) was downgraded to B from B+ on 2/8/2016 due to a decline in the volatility index and solvency index.
B
Buy 1/28/2016Downgrade
Anthem, Inc. (ANTM) was downgraded to B+ from A- on 1/28/2016 due to a large decline in the volatility index.
A
Buy 11/11/2015Downgrade
Anthem, Inc. (ANTM) was downgraded to A- from A on 11/11/2015 due to a large decline in the total return index, volatility index and growth index. Operating cash flow declined 70.72% from $1.17B to $343.4M, EBIT declined 24.4% from $1.71B to $1.29B, and earnings per share declined from $3.13 to $2.43.
A
Buy 7/31/2015Downgrade
Anthem, Inc. (ANTM) was downgraded to A from A+ on 7/31/2015 due to a substantial decline in the growth index, total return index and solvency index. Operating cash flow declined 28.93% from $1.65B to $1.17B, debt to equity increased from 0.73 to 0.8, and EBIT declined 1.02% from $1.73B to $1.71B.
A
Buy 5/1/2015Upgraded
Anthem, Inc. (ANTM) was upgraded to A+ from A on 5/1/2015 due to a significant increase in the growth index, volatility index and valuation index. Operating cash flow increased 440.97% from $305.1M to $1.65B, earnings per share increased from $1.8009 to $3.09, and EBIT increased 65.89% from $1.04B to $1.73B.
A
Buy 3/30/2015Upgraded
Anthem, Inc. (ANTM) was upgraded to A from A- on 3/30/2015 due to an increase in the volatility index, total return index and solvency index.
A
Buy 2/26/2015Upgraded
Anthem, Inc. (ANTM) was upgraded to A- from B+ on 2/26/2015 due to a noticeable increase in the growth index, total return index and valuation index. Total revenue increased 2.3% from $18.56B to $18.98B.
B
Buy 12/16/2014Downgrade
Anthem, Inc. (ANTM) was downgraded to B+ from A- on 12/16/2014 due to a decline in the total return index, volatility index and solvency index.
A
Buy 12/1/2014Upgraded
WellPoint Inc. (WLP) was upgraded to A- from B+ on 12/1/2014 due to a large increase in the total return index and solvency index.
B
Buy 11/14/2014Downgrade
WellPoint Inc. (WLP) was downgraded to B+ from A- on 11/14/2014 due to a significant decline in the growth index, valuation index and total return index. Operating cash flow declined 43.45% from $1.07B to $605.7M, earnings per share declined from $2.56 to $2.22, and EBIT declined 6.73% from $1.41B to $1.32B.
A
Buy 6/4/2014Downgrade
WellPoint Inc. (WLP) was downgraded to A- from A on 6/4/2014 due to a decline in the volatility index and valuation index.
A
Buy 5/20/2014Upgraded
WellPoint Inc. (WLP) was upgraded to A from A- on 5/20/2014 due to an increase in the growth index, total return index and valuation index.
A
Buy 5/5/2014Downgrade
WellPoint Inc. (WLP) was downgraded to A- from A on 5/5/2014 due to a decline in the valuation index, solvency index and efficiency index. Debt to equity increased from 0.62 to 0.67, and the quick ratio declined from 1.57 to 1.5.
A
Buy 4/16/2014Upgraded
WellPoint Inc. (WLP) was upgraded to A from A- on 4/16/2014 due to an increase in the volatility index, valuation index and total return index.
A
Buy 3/28/2014Upgraded
WellPoint Inc. (WLP) was upgraded to A- from B on 3/28/2014 due to a significant increase in the growth index, volatility index and total return index.
Weiss Ratings